13
Steven Laureys studies the brain of Tibetan
Buddhist monk Matthieu Ricard
What happens in the brain during meditation? The neurolo-
gists are more and more interested in that subject, and, thanks
to medical imaging tools (IRMf, Pet-Scan, TMS-EEG, etc…),
they are trying to discover neuronal correlates of a brain in
full meditation. Steven Laureys is exploring this new research
path. In May, he hosted the Tibetan Buddhist monk Mathieu
Ricard who underwent a series of tests on his brain at rest,
during meditation.
Steven Laureys explains : «Our goal is to put to the test theories
previously studied about consciousness during sleep, coma,
anesthesia and hypnosis. Is there a brain modification during
meditation? Does meditating involves a «flat
»
brain? I don’t
think so, because meditation is a neuronal «activity
»
and it
must be possible to set objective measures of a subjective tale
with the help of medical imaging. This might show an intense
activity of brain waves or a high use of glucose during medita-
tion
»
. A conference brought to a close this week of tests.
Wanderings of the mind and signs of
consciousness
Declaring the state of consciousness of severely brain-
damaged patients who are incapable of communication
remains a challenge for physicians. Clinical evaluation of
these people is traditionally based on examination of their
motor responses with the help of behavioural scales. Interes-
tingly, these patients can be paralysed, deaf, blind, suffering
from aphasia or attention deficit disorders, which may lead to
an underestimation of their level of consciousness. According
to a study published in 2009 in BMC Neurology, the risk of
misdiagnosis has been estimated at 40%. Nevertheless,
the systematic use of the “Coma Recovery Scale-Revised”
(CRS-R), a standardised and sensitive behavioural scale deve-
loped in the US by Joseph Giacino at the New Jersey Neuros-
cience Institute and validated in French and Dutch by Caroline
Schnakers and Steven Laureys of the Coma Science Group,
reduced the percentage of misdiagnosis rate to 31%.
Read the complete article (and others about Coma Science
group’s researches) on
www.reflexions.ulg.ac.be.